SODOLISTIM 1MIU INJ

Product Description

SODOLISTIM 1MIU INJ is a potent, hospital-grade antibiotic injection containing Colistimethate Sodium (1Million IU), specifically formulated for treating multi-drug resistant (MDR) gram-negative bacterial infections. It is widely used in ICU settings, making it an essential choice for critical care, pulmonology, and infectious disease management.

Manufactured under WHO-GMP certified facilities, SODOLISTIM ensures high purity, rapid bactericidal action, and trusted efficacy in combating resistant infections, especially pneumonia, urinary tract infections, and septicemia caused by Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae.

Key Benefits:

• Contains Colistimethate Sodium 1Million IU ideal for MDR infection treatment

• Effective in nosocomial infections and ICU-acquired pneumonia

• Complies with GMP and pharmacopoeial standards

• Trusted by hospitals, critical care units, and infection specialists

Applications:

• Used in treating life-threatening gram-negative bacterial infections

• Administered in hospital and clinical settings

• Suitable for intravenous use under medical supervision

Why Choose SODOLISTIM 1MIU INJ?

• High demand product in the critical care segment

• Ready for bulk supply, institutional tenders, and hospital procurement

• Competitive pricing with assured stock availability